This page is available in multiple languages
Select Language

Listing BenevolentAI – Gong ceremony

Back

Joanna Shields, CEO of BenevolentAI, and her team sounded the Gong this morning to celebrate the listing of the company on Euronext Amsterdam. BenevolentAI is a leading, clinical-stage AI-enabled drug discovery company that got listed on Euronext Amsterdam following a business combination with the Special Purpose Acquisition Company (SPAC) Odyssey Acquisition S.A.. They were welcomed by Simone Huis in ‘t Veld (CEO Euronext Amsterdam) and René van Vlerken (Head of Listing Euronext Amsterdam).